Vaxcyte Chart News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Vaxcyte Chart. Real-time updates on events, politics, business and more.

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

February 3, 2024

03.02.2024 - SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) - Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the ...

United States New York North Carolina Janet Graesser Jennifer Zibuda Sutro Biopharma Inc

Source: wallstreet-online.de

Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs)

October 16, 2023

16.10.2023 - - New Agreement to Establish Global Commercial Manufacturing Capacity for Vaxcytes PCV Candidates, VAX-24 and VAX-31, in Adult and Pediatric Populations - - Expanded Collaboration Builds on Vaxcyte’s Current Strategy to Conduct Initial Commercial ... Seite 1

Switzerland General Vaxcyte Inc Stage Clinical Development Standing Relationship Between Companies Further Enhanced Vaxcyte Progresses Lead Vaccine Candidate

Source: wallstreet-online.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Vaxcyte Chart News Today

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs)

Explore More Categories